- Home
- ARR vs SPRY Comparison
ARR vs SPRY Comparison
Compare ARR & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARR
- SPRY
- Stock Information
- Founded
- ARR 2008
- SPRY 2015
- Country
- ARR United States
- SPRY United States
- Employees
- ARR N/A
- SPRY N/A
- Industry
- ARR Real Estate Investment Trusts
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- ARR Real Estate
- SPRY Health Care
- Exchange
- ARR Nasdaq
- SPRY Nasdaq
- Market Cap
- ARR 1.8B
- SPRY 1.8B
- IPO Year
- ARR N/A
- SPRY N/A
- Fundamental
- Price
- ARR $14.94
- SPRY $9.74
- Analyst Decision
- ARR Buy
- SPRY Strong Buy
- Analyst Count
- ARR 4
- SPRY 5
- Target Price
- ARR $15.50
- SPRY $31.00
- AVG Volume (30 Days)
- ARR 3.1M
- SPRY 3.1M
- Earning Date
- ARR 10-22-2025
- SPRY 11-12-2025
- Dividend Yield
- ARR 19.12%
- SPRY N/A
- EPS Growth
- ARR N/A
- SPRY N/A
- EPS
- ARR N/A
- SPRY N/A
- Revenue
- ARR $20,589,000.00
- SPRY $112,339,000.00
- Revenue This Year
- ARR $378.40
- SPRY N/A
- Revenue Next Year
- ARR $40.72
- SPRY $182.40
- P/E Ratio
- ARR N/A
- SPRY N/A
- Revenue Growth
- ARR N/A
- SPRY 22367.80
- 52 Week Low
- ARR $13.18
- SPRY $9.78
- 52 Week High
- ARR $21.08
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- ARR 39.41
- SPRY 24.39
- Support Level
- ARR $15.01
- SPRY $9.97
- Resistance Level
- ARR $15.93
- SPRY $10.78
- Average True Range (ATR)
- ARR 0.25
- SPRY 0.65
- MACD
- ARR 0.01
- SPRY -0.04
- Stochastic Oscillator
- ARR 1.50
- SPRY 0.64
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.